• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

piRNA-14633 通过 METTL14 依赖性 m6A RNA 甲基化促进宫颈癌恶性进展。

piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.

机构信息

Department of Pathology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University; People's Hospital of Henan University, Zhengzhou, Henan, 450003, People's Republic of China.

Henan International Medical Center, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University; People's Hospital of Henan University, Zhengzhou, Henan, 450003, People's Republic of China.

出版信息

J Transl Med. 2022 Jan 29;20(1):51. doi: 10.1186/s12967-022-03257-2.

DOI:10.1186/s12967-022-03257-2
PMID:35093098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8802215/
Abstract

BACKGROUND

Cervical cancer (CC) is one of the most common gynecological tumors that threatens women's health and lives. Aberrant expression of PIWI-interacting RNA (piRNA) is closely related with a range of cancers and can serve as a tumor promoter or suppressor in proliferation, migration and invasion. In this study, the aim was not only to discover differential expression of piRNA in CC tissue (CC cells) and normal cervical tissue (normal cervical epithelium cells), but also to investigate the biological function and action mechanism of piRNA in CC.

METHODS

The DESeq2 approach was used to estimate fold change in piRNA between CC tissue and normal cervical tissue. The relative expressions of piRNAs (piRNA-20657, piRNA-20497, piRNA-14633 and piRNA-13350) and RNA m6A methyltransferases/demethylases were detected using RT-qPCR. After intervention with piRNA-14633 and METTL14 expression, the viability of CaSki cells and SiHa cells was detected by CCK8. CC cell proliferation was detected by colony formation assay. Apoptosis rate and cell cycle were detected by flow cytometry. Transwell assay was performed to detect cell migration and invasion. EpiQuik m6A RNA Methylation Quantification Kit was used to evaluate m6A RNA methylation levels. Expression of methyltransferase-like protein 14 (METTL14), PIWIL-proteins and CYP1B1 were detected by RT-qPCR and western blot. The effect of piRNA-14633 on METTL14 was evaluated by a dual-luciferase reporter assay. The in vivo effects of piRNA-14633 on CC was assessed by nude mice experiments.

RESULTS

piRNA-14633 showed high expression in CC tissues and cells, piRNA-14633 mimic (piRNA-14633 overexpression) promoted viability, proliferation, migration and invasion of CaSki cells and SiHa cells. Besides, piRNA-14633 mimic increased m6A RNA methylation levels and METTL14 mRNA stability. Results of dual luciferase reporter assays indicated that METTL14 was a directed target gene of piRNA-14633. Knockdown of METTL14 with siRNA attenuated proliferation, migration and invasion of CC cells. piRNA-14633 increased CYP1B1 expression, while silencing of METTL14 impaired its expression. The effect of piRNA overexpression on METTL14 expression has concentration-dependent characteristics. Results from in vivo experiment indicated that piRNA-14633 promoted cervical tumor growth.

CONCLUSION

piRNA-14633 promotes proliferation, migration and invasion of CC cells by METTL14/CYP1B1 signaling axis, highlighting the important role of piRNA-14633 in CC.

摘要

背景

宫颈癌(CC)是威胁女性健康和生命的最常见妇科肿瘤之一。PIWI 相互作用 RNA(piRNA)的异常表达与多种癌症密切相关,可作为增殖、迁移和侵袭的肿瘤促进因子或抑制因子。本研究不仅旨在发现 CC 组织(CC 细胞)和正常宫颈组织(正常宫颈上皮细胞)中 piRNA 的差异表达,还旨在研究 piRNA 在 CC 中的生物学功能和作用机制。

方法

使用 DESeq2 方法估计 piRNA 在 CC 组织和正常宫颈组织之间的倍数变化。使用 RT-qPCR 检测 piRNA(piRNA-20657、piRNA-20497、piRNA-14633 和 piRNA-13350)和 RNA m6A 甲基转移酶/去甲基酶的相对表达。用 piRNA-14633 和 METTL14 表达干预后,通过 CCK8 检测 CaSki 细胞和 SiHa 细胞的活力。通过集落形成实验检测 CC 细胞的增殖。通过流式细胞术检测细胞凋亡率和细胞周期。通过 Transwell 测定法检测细胞迁移和侵袭。EpiQuik m6A RNA 甲基化定量试剂盒用于评估 m6A RNA 甲基化水平。使用 RT-qPCR 和 Western blot 检测甲基转移酶样蛋白 14(METTL14)、PIWIL 蛋白和 CYP1B1 的表达。通过双荧光素酶报告基因测定评估 piRNA-14633 对 METTL14 的影响。通过裸鼠实验评估 piRNA-14633 对 CC 的体内影响。

结果

piRNA-14633 在 CC 组织和细胞中高表达,piRNA-14633 模拟物(piRNA-14633 过表达)促进了 CaSki 细胞和 SiHa 细胞的活力、增殖、迁移和侵袭。此外,piRNA-14633 模拟物增加了 m6A RNA 甲基化水平和 METTL14 mRNA 的稳定性。双荧光素酶报告基因测定结果表明,METTL14 是 piRNA-14633 的直接靶基因。用 siRNA 敲低 METTL14 可减弱 CC 细胞的增殖、迁移和侵袭。piRNA-14633 增加了 CYP1B1 的表达,而 METTL14 的沉默则削弱了其表达。piRNA 过表达对 METTL14 表达的影响具有浓度依赖性特征。体内实验结果表明,piRNA-14633 促进了宫颈肿瘤的生长。

结论

piRNA-14633 通过 METTL14/CYP1B1 信号轴促进 CC 细胞的增殖、迁移和侵袭,突出了 piRNA-14633 在 CC 中的重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/1a00392da80a/12967_2022_3257_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/6712d107897f/12967_2022_3257_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/1846ad64f969/12967_2022_3257_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/c27d6c3b7a7e/12967_2022_3257_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/5016d2b865d8/12967_2022_3257_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/808e23697159/12967_2022_3257_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/dd1003459914/12967_2022_3257_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/6092ff0dce9c/12967_2022_3257_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/dd193272074c/12967_2022_3257_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/a876713d8bd8/12967_2022_3257_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/0029d3dcdbb4/12967_2022_3257_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/1a00392da80a/12967_2022_3257_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/6712d107897f/12967_2022_3257_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/1846ad64f969/12967_2022_3257_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/c27d6c3b7a7e/12967_2022_3257_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/5016d2b865d8/12967_2022_3257_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/808e23697159/12967_2022_3257_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/dd1003459914/12967_2022_3257_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/6092ff0dce9c/12967_2022_3257_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/dd193272074c/12967_2022_3257_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/a876713d8bd8/12967_2022_3257_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/0029d3dcdbb4/12967_2022_3257_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e318/8802215/1a00392da80a/12967_2022_3257_Fig11_HTML.jpg

相似文献

1
piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.piRNA-14633 通过 METTL14 依赖性 m6A RNA 甲基化促进宫颈癌恶性进展。
J Transl Med. 2022 Jan 29;20(1):51. doi: 10.1186/s12967-022-03257-2.
2
METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer.METTL14 通过 m6A 甲基化降低 FTH1 mRNA 稳定性以促进索拉非尼诱导的宫颈癌铁死亡。
Cancer Biol Ther. 2024 Dec 31;25(1):2349429. doi: 10.1080/15384047.2024.2349429. Epub 2024 May 13.
3
PIWI-interacting RNA-17458 is oncogenic and a potential therapeutic target in cervical cancer.PIWI相互作用RNA-17458具有致癌性,是宫颈癌的一个潜在治疗靶点。
J Cancer. 2023 Jun 4;14(9):1648-1659. doi: 10.7150/jca.83446. eCollection 2023.
4
M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C.M6A 诱导的转录因子 IRF5 通过上调 PPP6C 促进宫颈癌的进展。
Clin Exp Pharmacol Physiol. 2024 Jul;51(7):e13868. doi: 10.1111/1440-1681.13868.
5
N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma.METTL14/IGF2BP3 介导的 FSCN1 上的 N6-甲基腺苷甲基化促进了人乳头瘤病毒 16 感染的宫颈鳞状细胞癌。
Clin Exp Pharmacol Physiol. 2024 Jun;51(6):e13864. doi: 10.1111/1440-1681.13864.
6
METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.METTL14 通过调节 N6-甲基腺苷和 hsa-miR-146a-5p 的表达促进乳腺癌细胞的迁移和侵袭。
Oncol Rep. 2020 May;43(5):1375-1386. doi: 10.3892/or.2020.7515. Epub 2020 Feb 24.
7
[METTL14 promotes the proliferation and migration of cervical cancer cells by up-regulating mA Myc expression].[METTL14通过上调mA Myc表达促进宫颈癌细胞的增殖和迁移]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2022 Feb;38(2):131-137.
8
METTL14 contributes to the progression of nasopharyngeal carcinoma through regulating the stability of AOC1 mRNA.METTL14 通过调控 AOC1 mRNA 的稳定性促进鼻咽癌的进展。
Hereditas. 2024 Jul 2;161(1):20. doi: 10.1186/s41065-024-00317-z.
9
METTL14 Suppresses Tumor Stemness and Metastasis of Colon Cancer Cells by Modulating m6A-Modified SCD1.METTL14 通过调控 m6A 修饰的 SCD1 抑制结肠癌细胞的肿瘤干性和转移。
Mol Biotechnol. 2024 Aug;66(8):2095-2105. doi: 10.1007/s12033-023-00843-7. Epub 2023 Aug 17.
10
METTL3 Regulates the Translation of Oncogene Myc through mA Modification and Promotes the Occurrence and Development of Cervical Cancer.METTL3 通过 mA 修饰调控癌基因 Myc 的翻译并促进宫颈癌的发生发展。
Discov Med. 2024 Sep;36(188):1902-1910. doi: 10.24976/Discov.Med.202436188.176.

引用本文的文献

1
Machine learning model for early diagnosis of breast cancer based on PiRNA expression with CA153.基于PiRNA表达与CA153的乳腺癌早期诊断机器学习模型
Sci Rep. 2025 Aug 20;15(1):30586. doi: 10.1038/s41598-025-15431-9.
2
The Role of PIWI-Interacting RNA in Urologic Carcinoma and Its Clinical Implications.PIWI相互作用RNA在泌尿系统肿瘤中的作用及其临床意义。
Cancer Rep (Hoboken). 2025 Aug;8(8):e70272. doi: 10.1002/cnr2.70272.
3
N6-methyladenosine in cervical carcinogenesis: Mechanistic insights and therapeutic perspectives (Review).

本文引用的文献

1
Cytochrome P450 1B1 Overexpression in Cervical Cancers: Cross-sectional Study.细胞色素P450 1B1在宫颈癌中的过表达:横断面研究
Interact J Med Res. 2021 Oct 12;10(4):e31150. doi: 10.2196/31150.
2
Identification of an immune classification for cervical cancer and integrative analysis of multiomics data.识别宫颈癌的免疫分类并综合分析多组学数据。
J Transl Med. 2021 May 10;19(1):200. doi: 10.1186/s12967-021-02845-y.
3
Emerging functions of piwi-interacting RNAs in diseases.piRNA 在疾病中的新兴功能。
N6-甲基腺苷在宫颈癌发生中的作用机制及治疗前景(综述)
Oncol Lett. 2025 Jul 14;30(3):442. doi: 10.3892/ol.2025.15188. eCollection 2025 Sep.
4
Chemically modified non-coding RNAs in cancer.癌症中的化学修饰非编码RNA
Expert Rev Mol Med. 2025 Jun 9;27:e19. doi: 10.1017/erm.2025.10007.
5
Cancer-associated fibroblasts-derived exosomal piR-35462 promotes the progression of oral squamous cell carcinoma via FTO/Twist1 pathway.癌症相关成纤维细胞衍生的外泌体piR-35462通过FTO/Twist1途径促进口腔鳞状细胞癌的进展。
BMC Oral Health. 2025 May 28;25(1):840. doi: 10.1186/s12903-025-06082-3.
6
Polyphyllin I Inhibits the Metastasis of Cervical Cancer Through the Regulation of the β-Catenin Signaling Pathway.重楼皂苷I通过调控β-连环蛋白信号通路抑制宫颈癌转移。
Int J Mol Sci. 2025 May 12;26(10):4630. doi: 10.3390/ijms26104630.
7
Reciprocal regulation between m6 A modifications and non-coding RNAs: emerging roles in cancer therapeutic resistance.m6A修饰与非编码RNA之间的相互调控:在癌症治疗耐药性中的新作用
Discov Oncol. 2025 May 25;16(1):920. doi: 10.1007/s12672-025-02641-w.
8
Application of non‑coding RNAs in tumors (Review).非编码RNA在肿瘤中的应用(综述)
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13529. Epub 2025 Apr 11.
9
PPDAMEGCN: Predicting piRNA-Disease Associations Based on Multi-Edge Type Graph Convolutional Network.PPDAMEGCN:基于多边缘类型图卷积网络预测piRNA与疾病的关联
IET Syst Biol. 2025 Jan-Dec;19(1):e70011. doi: 10.1049/syb2.70011.
10
piRNA/PIWI pathways and epigenetic crosstalk in human diseases: Molecular insights into HIV-1 infection and drugs of abuse.piRNA/PIWI通路与人类疾病中的表观遗传串扰:对HIV-1感染及滥用药物的分子见解
Mol Ther Nucleic Acids. 2025 Feb 1;36(1):102473. doi: 10.1016/j.omtn.2025.102473. eCollection 2025 Mar 11.
J Cell Mol Med. 2021 Jun;25(11):4893-4901. doi: 10.1111/jcmm.16466. Epub 2021 May 4.
4
YTHDF1 Aggravates the Progression of Cervical Cancer Through mA-Mediated Up-Regulation of RANBP2.YTHDF1通过mA介导的RANBP2上调促进宫颈癌进展。
Front Oncol. 2021 Mar 19;11:650383. doi: 10.3389/fonc.2021.650383. eCollection 2021.
5
piRNA-823 Is Involved in Cancer Stem Cell Regulation Through Altering DNA Methylation in Association With Luminal Breast Cancer.piRNA - 823通过改变DNA甲基化参与管腔型乳腺癌中癌症干细胞的调控。
Front Cell Dev Biol. 2021 Mar 15;9:641052. doi: 10.3389/fcell.2021.641052. eCollection 2021.
6
The Impact of m6A RNA Modification in Therapy Resistance of Cancer: Implication in Chemotherapy, Radiotherapy, and Immunotherapy.m6A RNA修饰对癌症治疗耐药性的影响:在化疗、放疗和免疫治疗中的意义
Front Oncol. 2021 Feb 25;10:612337. doi: 10.3389/fonc.2020.612337. eCollection 2020.
7
piRNAs as Modulators of Disease Pathogenesis.piRNAs 作为疾病发病机制的调节剂。
Int J Mol Sci. 2021 Feb 27;22(5):2373. doi: 10.3390/ijms22052373.
8
Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data.通过整合 DNA 甲基化、拷贝数变异和转录组数据,鉴定了宫颈癌的 8 个长链非编码 RNA 特征。
J Transl Med. 2021 Feb 8;19(1):58. doi: 10.1186/s12967-021-02705-9.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer.抑制 Kpnβ1 介导的核输入可增强宫颈癌对顺铂的化疗敏感性。
BMC Cancer. 2021 Feb 2;21(1):106. doi: 10.1186/s12885-021-07819-3.